← Eichor
Study identifier: NCT06723197 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Efficacy of Different Durations of Dual and Quadruple Regimens for Helicobacter Pylori Eradication

Condition: HELICOBACTER PYLORI INFECTIONS  ·  Sponsor: Shandong University

PhasePhase 4
Planned participants330
Who can joinAll sexes, 18 Years to 70 Years
Healthy volunteersNo

About this study

The study aimed to compare the efficacy and safety of dual and quadruple regimens with different durations (7-day, 10-day, 14-day) for the eradication of Helicobacter pylori. Subjects were randomized to receive the intervention and were reviewed by 13C-urea breath test after 6 weeks. The eradication rates, adverse reaction rates and patient adherence were calculated.

This description comes directly from the study's public registry record.

Talk to the study team

Yanqing Li, Ph.D  ·  +8653188369277  ·  liyanqing@sdu.edu.cn

Always discuss trial participation with your own doctor first.

Locations (1)

Qilu Hospital of Shandong UniversityJinan, Shandong, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06723197